+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Extracorporeal Membrane Oxygenation Machine Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 197 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5014105
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers require reliable guidance to navigate evolving dynamics in the ECMO machine market. This report delivers strategic insight, expertly analyzing the sector to support clinical leadership as they respond to emergent care demands and complex regulatory shifts.

Market Snapshot: ECMO Machine Market Outlook

The extracorporeal membrane oxygenation (ECMO) machine market is marked by robust global expansion, driven by notable advances in device design and broader integration across complex care settings. In 2024, the ECMO machine market is forecast to reach USD 551.19 million, supported by a compound annual growth rate of 5.40%. Enhancements in device functionalities, safer iterative designs, and the extension of applications from acute to chronic care are accelerating adoption worldwide. Hospitals and specialized clinical centers prioritize modernization to remain in step with evolving treatment protocols, while ongoing regulatory change shapes both procurement patterns and system integration across regions. As new technologies emerge, organizations are increasingly focused on integrating ECMO solutions to address both urgent and long-term patient needs.

Scope & Segmentation of the ECMO Machine Market

This report is developed for senior executives handling strategic planning, benchmarking, and competitive analysis in critical care technology. Comprehensive segmentation helps leaders evaluate relevant developments, with detailed focus in the following areas:

  • Device Types: Venoarterial and venovenous ECMO systems provide tailored support for cardiac and respiratory interventions, enabling multidisciplinary clinical teams to address a wide range of care scenarios.
  • Component Types: Cannulae, controllers, heat exchangers, oxygenators, and pump units are fundamental for ensuring operational reliability, patient safety, and performance consistency in diverse clinical environments.
  • Patient Types: ECMO therapies are adapted for adults, infants, and pediatric cases, allowing customization to the unique requirements of neonatal, pediatric, and adult care settings.
  • Applications: The market covers cardiac care, extracorporeal cardiopulmonary resuscitation (ECPR), and advanced respiratory support, spanning both planned and emergency interventions to support critical patient outcomes.
  • End Users: Hospitals, ambulatory surgical centers, and specialty clinics deploy ECMO technology to enhance clinical workflows and manage the needs of patients with significant medical complexity.
  • Regions: Adoption rates vary across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by distinct healthcare infrastructures, regulatory frameworks, and procurement approaches.
  • Leading Companies: Key market participants such as Getinge AB, Medtronic plc, LivaNova PLC, and Terumo Corporation advance the sector through focused innovation and strategic distribution.
  • Technologies: Technological advancements include centrifugal and roller pump systems, new-generation membrane materials, digital monitoring overlays, and artificial intelligence-driven solutions to ensure seamless workflow integration and efficiency.

Key Takeaways for Senior Decision-Makers

  • Rapid innovation in ECMO device design and pump technology is supporting clinical teams in managing a broader array of challenging cases while fostering better interdisciplinary collaboration.
  • Wider adoption of ECMO systems has enabled care providers to respond promptly to critical conditions and individualize patient treatment pathways, resulting in improved clinical continuity.
  • Cross-functional integration of clinical, technical, and engineering disciplines enhances guideline development and ensures ongoing compatibility as new systems are introduced in high-acuity environments.
  • Recent advances in automation and sensitive sensor deployment allow for continuous patient monitoring and enable staff to make care adjustments with minimal workflow interruption.
  • Strategies diverge by region: developed healthcare markets emphasize upgrading technology and building advanced team skills, while emerging markets focus on expanding capacity and adopting flexible procurement models.
  • Critical care organizations now recognize the importance of continuous professional education to maximize ECMO value and minimize learning curves when integrating new solutions.

Tariff Impact: Strategic Responses to US Policy Changes in 2025

Forthcoming US tariff changes are prompting healthcare procurement leaders to reexamine sourcing strategies and supplier networks for ECMO devices. Emphasis is increasing on strengthening supplier relationships and considering nearshoring to bolster supply chain stability. Group purchasing frameworks are being utilized for risk mitigation, and transitioning to reusable components or advanced materials assists in maintaining uninterrupted device access amidst evolving regulatory pressures.

Methodology & Data Sources

The report integrates secondary ECMO machine market research, in-depth interviews with industry specialists, and broad benchmarking of leading products. Strategic frameworks—including SWOT analysis, Porter’s Five Forces, and scenario planning—inform the insights relevant for high-level decision-making.

Why This Report Matters

  • Enables senior leaders to proactively address regulatory updates and strategically invest in emerging technologies as part of their critical care operations.
  • Empowers procurement and clinical management teams with granular ECMO market intelligence to guide resource allocation and improve efficiency within complex healthcare settings.
  • Provides organizations with actionable insight to refine patient care strategies and maintain future-ready clinical infrastructure for ongoing resilience.

Conclusion

This ECMO machine market report delivers timely, actionable intelligence for senior leadership, supporting the alignment of clinical, operational, and supplier strategies to ensure resilient, adaptive healthcare delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of artificial intelligence algorithms for real-time ECMO circuit parameter optimization
5.2. Emergence of portable and transportable ECMO systems enabling point-of-care lifesaving interventions
5.3. Development of biocompatible polymer coatings to reduce thrombosis in prolonged ECMO support applications
5.4. Expansion of venoarterial ECMO utilization in adult cardiogenic shock management and mobile ECMO teams
5.5. Advancements in low-resistance hollow fiber oxygenators for improved neonatal and pediatric ECMO outcomes
5.6. Regulatory approvals driving adoption of miniaturized extracorporeal life support devices in ambulatory care
5.7. Collaborations between medical device and software firms for integrated ECMO digital monitoring platforms
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Extracorporeal Membrane Oxygenation Machine Market, by Device Type
8.1. Veno Arterial
8.2. Veno Venous
9. Extracorporeal Membrane Oxygenation Machine Market, by Component Type
9.1. Cannula
9.2. Controllers
9.3. Heat Exchangers
9.4. Oxygenators
9.5. Pumps
10. Extracorporeal Membrane Oxygenation Machine Market, by Patient Type
10.1. Adults
10.2. Infants
10.3. Pediatric
11. Extracorporeal Membrane Oxygenation Machine Market, by Application
11.1. Cardiac Support
11.1.1. Cardiogenic Shock
11.1.2. Post Cardiotomy
11.2. Extracorporeal Cardiopulmonary Resuscitation
11.3. Respiratory Support
12. Extracorporeal Membrane Oxygenation Machine Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Hospitals
12.3. Specialty Clinics
13. Extracorporeal Membrane Oxygenation Machine Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Extracorporeal Membrane Oxygenation Machine Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Extracorporeal Membrane Oxygenation Machine Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Getinge AB
16.3.2. Medtronic plc
16.3.3. LivaNova PLC
16.3.4. Terumo Corporation
16.3.5. Fresenius Medical Care
16.3.6. Hemovent N.V.
16.3.7. Spectrum Medical (UK) Limited
16.3.8. B. Braun Melsungen AG
16.3.9. Baxter International Inc.
16.3.10. Abiomed, Inc.
16.3.11. Abbott Laboratories
16.3.12. MicroPort Scientific Corporation
16.3.13. Nipro Corporation
16.3.14. OriGen Biomedical, Inc.
16.3.15. CytoSorbents Corporation
16.3.16. Senko Medical Instrument Mfg. Co., Ltd.
16.3.17. Braile Biomedica
16.3.18. Spectrum Medical Ltd.
16.3.19. Inspira Technologies OXY B.H.N. Ltd.
16.3.20. Eurosets S.r.l.

Companies Mentioned

The companies profiled in this Extracorporeal Membrane Oxygenation Machine market report include:
  • Getinge AB
  • Medtronic plc
  • LivaNova PLC
  • Terumo Corporation
  • Fresenius Medical Care
  • Hemovent N.V.
  • Spectrum Medical (UK) Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Abiomed, Inc.
  • Abbott Laboratories
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OriGen Biomedical, Inc.
  • CytoSorbents Corporation
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Braile Biomedica
  • Spectrum Medical Ltd.
  • Inspira Technologies OXY B.H.N. Ltd.
  • Eurosets S.r.l.

Table Information